Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 25, 2019 Filed Oct 28, 2019 20:33 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,172 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-011249 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,172 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 20:33 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,172 | $78.00 | $91,416.00 |
DisclosureSEC source: 0001179110-19-011249 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,487 F4 · shares: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4, the shares were all sold at an exact price of $78.00. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 20:33 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-011249 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 21, 2019 Filed Oct 21, 2019 23:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 25,926 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-011153 · edgar.xml · derivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,926 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2019 Filed Oct 21, 2019 23:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 25,926 | $78.03 | $2,022,990.22 |
DisclosureSEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,487 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F7 · price: The price reported in Column 4 is the average price of $78.0294. The sold price range between $78.00 to $78.21. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 21, 2019 Filed Oct 21, 2019 23:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 25,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
| October 18, 2019 Filed Oct 18, 2019 22:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 400 | $76.87 | $30,747.00 |
DisclosureSEC source: 0001179110-19-011130 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,409 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F6 · price: The price reported in Column 4 is the average price of $76.8675. The sold price range between $76.72 to $77.7199. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2019 Filed Oct 18, 2019 22:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 3,500 | $76.22 | $266,766.15 |
DisclosureSEC source: 0001179110-19-011130 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,809 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F5 · price: The price reported in Column 4 is the average price of $76.2189. The sold price range between $75.65 to $76.6499. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2019 Filed Oct 18, 2019 22:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,100 | $75.17 | $82,688.98 |
DisclosureSEC source: 0001179110-19-011130 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 293,309 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $75.1718. The sold price range between $74.64 to $75.6399. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2019 Filed Oct 21, 2019 23:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 400 | $76.87 | $30,747.00 |
DisclosureSEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,409 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F6 · price: The price reported in Column 4 is the average price of $76.8675. The sold price range between $76.72 to $77.7199. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2019 Filed Oct 21, 2019 23:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 3,500 | $76.22 | $266,766.15 |
DisclosureSEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,809 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F5 · price: The price reported in Column 4 is the average price of $76.2189. The sold price range between $75.65 to $76.6499. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2019 Filed Oct 21, 2019 23:01 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,100 | $75.17 | $82,688.98 |
DisclosureSEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 293,309 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $75.1718. The sold price range between $74.64 to $75.6399. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 11, 2019 Filed Oct 11, 2019 22:02 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,534 | $0.00 Strike: $43.30 | $0.00 |
DisclosureSEC source: 0001179110-19-010958 · edgar.xml · derivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,534 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 11, 2019 Filed Oct 11, 2019 22:02 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,534 | $75.26 | $115,454.21 |
DisclosureSEC source: 0001179110-19-010958 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,333 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $75.2635. The sold price range between $75.18 to $75.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 11, 2019 Filed Oct 11, 2019 22:02 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-010958 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 15, 2019 Filed Sep 16, 2019 21:06 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 202 | $73.72 | $14,891.44 |
DisclosureSEC source: 0001179110-19-010372 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,258 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 13:17 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,300 | $75.17 | $97,719.05 |
DisclosureSEC source: 0001179110-19-010307 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,033 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $75.1685. The sold price range between $75.00 to $75.27. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2019 Filed Sep 30, 2019 21:43 UTC Amendment |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $43.30 | $0.00 |
DisclosureSEC source: 0001104659-19-052089 · a4a.xml · derivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,300 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Due to an administrative error, this sale was originally reported as a sale of directly owned shares; this amendment is being filed to correctly reflect that the sale was pursuant to an exercise of options and subsequent sale of underlying shares. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · shares: Due to an administrative error, this sale was originally reported as a sale of directly owned shares; this amendment is being filed to correctly reflect that the sale was pursuant to an exercise of options and subsequent sale of underlying shares. F2 · derivative.underlying_shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 12, 2019 Filed Sep 30, 2019 21:43 UTC Amendment |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,300 | $75.17 | $97,719.05 |
DisclosureSEC source: 0001104659-19-052089 · a4a.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,333 F3 · shares: Due to an administrative error, this sale was originally reported as a sale of directly owned shares; this amendment is being filed to correctly reflect that the sale was pursuant to an exercise of options and subsequent sale of underlying shares. Read SEC document |
| September 12, 2019 Filed Sep 30, 2019 21:43 UTC Amendment |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-052089 · a4a.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · shares: Due to an administrative error, this sale was originally reported as a sale of directly owned shares; this amendment is being filed to correctly reflect that the sale was pursuant to an exercise of options and subsequent sale of underlying shares. F1 · price: The price reported in Column 4 is the average price of $75.1685. The sold price range between $75.00 to $75.27. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 17:21 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStpck Options NQ (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-009959 · edgar.xml · derivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 17:21 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 1,252 | $71.71 | $89,776.16 |
DisclosureSEC source: 0001179110-19-009959 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,826 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $71.7062. The sold price range between $72.00 to $72.46. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 17:21 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 4,998 | $71.71 | $358,387.59 |
DisclosureSEC source: 0001179110-19-009959 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,078 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $71.7062. The sold price range between $71.27 to $71.93. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 17:21 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009959 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 25, 2019 Filed Jul 26, 2019 20:22 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 5,000 | $70.30 | $351,479.50 |
DisclosureSEC source: 0001179110-19-008842 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 294,409 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $70.2959. The sold price range between $70.01 to $70.58. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 21:39 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStpck Options NQ (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-008219 · edgar.xml · derivative · entry 7 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 21:39 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 223 | $86.23 | $19,230.09 |
DisclosureSEC source: 0001179110-19-008219 · edgar.xml · nonDerivative · entry 6 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,826 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $86.2336. The sold price range between $86.20 to $86.29. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 21:39 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 3,456 | $85.40 | $295,152.42 |
DisclosureSEC source: 0001179110-19-008219 · edgar.xml · nonDerivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,049 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $85.4029. The sold price range between $85.02 to $85.74. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 21:39 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 425 | $86.20 | $36,637.00 |
DisclosureSEC source: 0001179110-19-008219 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,505 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $86.2047. The sold price range between $86.15 to $86.24. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 21:39 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 5,825 | $85.43 | $497,632.08 |
DisclosureSEC source: 0001179110-19-008219 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $85.4304. The sold price range between $85.00 to $85.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 21:39 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-008219 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 20, 2019 Filed Jun 20, 2019 22:02 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Exercise / conversionThe sales reported in this Form 4 were effected pursuant to · Derivative | 4,852 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-19-007989 · edgar.xml · derivative · entry 7 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,852 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 20, 2019 Filed Jun 20, 2019 22:02 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
SaleCommon Stock | 4,852 | $87.08 | $422,512.16 |
DisclosureSEC source: 0001179110-19-007989 · edgar.xml · nonDerivative · entry 5 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,321 F3 · price: The price reported in Column 4, the shares were all sold at an exact price of $87.08. Read SEC document |
| June 20, 2019 Filed Jun 20, 2019 22:02 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Exercise / conversionCommon Stock | 4,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-007989 · edgar.xml · nonDerivative · entry 4 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:02 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 96 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-19-007989 · edgar.xml · derivative · entry 6 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:02 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
SaleCommon Stock | 96 | $87.00 | $8,352.00 |
DisclosureSEC source: 0001179110-19-007989 · edgar.xml · nonDerivative · entry 3 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,321 F2 · price: The price reported in Column 4, the shares were all sold at an exact price of $87.00. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:02 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Exercise / conversionCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-007989 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 22:48 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 332 | $82.05 | $27,240.23 |
DisclosureSEC source: 0001179110-19-007788 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,333 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $82.0489. The sold price range between $82.04 to $82.07. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 22:48 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,418 | $81.44 | $115,479.37 |
DisclosureSEC source: 0001179110-19-007788 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,665 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $81.4382. The sold price range between $80.98 to $81.97. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:23 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 202 | $81.03 | $16,368.06 |
DisclosureSEC source: 0001179110-19-007785 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,460 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:23 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 846 | $81.03 | $68,551.38 |
DisclosureSEC source: 0001179110-19-007784 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,083 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:22 UTC |
Kuipers Peter J.Executive V P& CFO
|
Tax withholdingCommon Stock | 4,866 | $81.03 | $394,291.98 |
DisclosureSEC source: 0001179110-19-007783 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,849 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:22 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Tax withholdingCommon Stock | 2,753 | $81.03 | $223,075.59 |
DisclosureSEC source: 0001179110-19-007782 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,505 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:21 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Tax withholdingCommon Stock | 2,813 | $81.03 | $227,937.39 |
DisclosureSEC source: 0001179110-19-007781 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,321 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:21 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 12,019 | $81.03 | $973,899.57 |
DisclosureSEC source: 0001179110-19-007780 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,487 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| May 30, 2019 Filed May 31, 2019 16:15 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
SaleCommon Stock | 4,901 | $79.68 | $390,512.17 |
DisclosureSEC source: 0001179110-19-006880 · edgar.xml · nonDerivative · entry 3 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,662 F2 · price: The price reported in Column 4 is the average price of $79.6801. The sold price range between $79.66 to $79.6628. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 30, 2019 Filed May 31, 2019 16:15 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
SaleCommon Stock | 1,549 | $79.43 | $123,033.66 |
DisclosureSEC source: 0001179110-19-006880 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,563 F1 · price: The price reported in Column 4 is the average price of $79.4278. The sold price range between $79.38 to $79.55. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 29, 2019 Filed Jun 17, 2019 21:21 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-007780 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 299,409 F4 · shares: Gifted on 5/29/19 to Donor advised Fund from Family trust account. Read SEC document |
| May 15, 2019 Filed May 15, 2019 23:25 UTC |
Smith Bruce D.Director
|
GrantCommon Stock | 2,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006117 · edgar.xml · nonDerivative · entry 2 Smith Bruce D. · CIK 0001635537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,267 F1 · shares: Grant of restricted shares in consideration of service as a Board member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:27 UTC |
Moore Vance B.Director
|
GrantCommon Stock | 2,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006120 · edgar.xml · nonDerivative · entry 2 Moore Vance B. · CIK 0001550553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,522 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.